John Paul Fiore

Previous clients:

• Hikma Specialty USA Inc
  (Details)

  Registered: 5/3/2024

  Ended: 3/28/2025

  Matters: Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing. Specifically, ensuring state/community access to opioid antagonists such as naloxone hydrochloride nasal spray (8 mg).

  Arrangement: No Longer Representing

  Government Alliances Director